Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring CAMD technique performance: a virtual screening case study in the design of validation experiments.

Andrew C Good1, Mark A Hermsmeier, S A Hindle

  • 1Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA. andrew.good@bms.com

Journal of Computer-Aided Molecular Design
|February 26, 2005
PubMed
Summary

This study validates computational chemistry algorithms for drug discovery. A new chemotype enrichment method assesses ligand-based virtual screening descriptors, offering guidelines for their optimal application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9.

Journal of medicinal chemistry·2025
Same author

GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1.

Journal of medicinal chemistry·2022
Same author

Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors.

ACS medicinal chemistry letters·2020
Same author

P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor.

Bioorganic & medicinal chemistry letters·2018
Same author

Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins.

Journal of medicinal chemistry·2018
Same author

Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor.

ACS medicinal chemistry letters·2018

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Novel computational chemistry algorithms are rapidly developed.
  • Lack of experimental validation hinders understanding of algorithm utility and limitations.

Purpose of the Study:

  • To address the lack of validation for ligand-based virtual screening descriptors.
  • To design validation experiments reflecting real-world applications.

Main Methods:

  • Applied a novel chemotype enrichment approach.
  • Compared various 2D/3D similarity descriptors across diverse target datasets.
  • Examined descriptor performance using typical virtual screening validation experiments.

Main Results:

Related Experiment Videos

  • Evaluated descriptor performance across datasets with varied inhibitor properties.
  • Identified relative strengths and weaknesses of different descriptors.
  • Assessed the utility of fingerprint filtering.

    • Conclusions:

    • Provided guidelines for optimal application of virtual screening descriptors.
    • Highlighted the importance of robust validation for computational methods.
    • Demonstrated the value of the chemotype enrichment approach.